Antiviral Screening Assays for Human Herpesviruses 6 and 7

  • Jodi B. Black
  • Philip E. Pellett
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 24)


Human herpesviruses 6 and 7 are ubiquitous herpesviruses that normally infect their hosts early in life. There are two variant groups of human herpesvirus 6 (HHV-6): variants A (HHV-6A) and B (HHV-6B). Variant A has not been unambiguously associated with a specific disease but may contribute to disease in immunocompromised patients; variant B is the major etiologic agent of roseola (roseola infantum or exanthem subitum) and other febrile illnesses of young children, and has been associated with disease in immunocompromised patients. HHV-6B is frequently present in plaque regions in the brains of multiple sclerosis patients, although an etiologic association has not been proven. Human herpesvirus 7 (HHV-7) has been associated with some cases of roseola. The clinical spectrum of these viruses remains to be completely defined. Braun et al. (1) recently described three clinical scenarios that might warrant the use of antivirals to treat HHV-6 infections: (1) transplant recipients with idiopathic pneumonitis (2), multiple sclerosis patients, and (3) patients with HHV-6-associated encephalitis. For HHV-7, cases of neurologic involvement during primary infection might warrant investigation (2).


Sodium Dodecyl Sulfate Multiple Sclerosis Patient Buffy Coat Uninfected Cell Infected Cell Culture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Braun, D. K., Dominguez, G., and Pellett, P. E. (1997) Human herpesvirus 6. Clin. Microbiol. Rev. 10, 521–567.PubMedGoogle Scholar
  2. 2.
    Torigoe, S., Koide, W., Yamada, M., Miyashiro, E., Tanaka-Taya, K., and Yamanishi, K. (1996) Human herpesvirus 7 infection associated with central nervous system manifestations. J. Pediatr. 129, 301–305.CrossRefPubMedGoogle Scholar
  3. 3.
    Pellett, P. E., Black, J. B., and Yamamoto, M. (1992) Human herpesvirus 6: the virus and the search for its role as a human pathogen. Adv. Virus Res. d41, 1–52.CrossRefGoogle Scholar
  4. 4.
    Williams, M. V. (1992) HHV-6: response to antiviral agents, in Human Herpesvirus-6: Epidemiology, Molecular Biology, and Clinical Pathology (Ablashi, D. V., Krueger, G. R. F., and Salabuddin, S. Z., eds.), Elsevier, Amsterdam, pp. 317–335.CrossRefGoogle Scholar
  5. 5.
    Pellett, P. E. and Black, J. B. (1996) Human herpesvirus 6, in Fields Virology, 3rd ed., vol. 2 (Fields, B. N., Knipe, D. M., Howley, P. M., Channock, R. M., Melnick, J. L., Monath, T. P., Roizman, B., and Straus, S. E., eds.), Lippincott-Raven, Philadelphia, PA, pp. 2587–2608.Google Scholar
  6. 6.
    Martin, M. E. D., Thomson, B. J., Honess, R. W., Craxton, M. A., Gompels, U. A., Liu, M. Y., Littler, E., Arrand, J. R., Teo, I., and Jones, M. D. (1991) The genome of human herpesvirus 6: maps of unit-length and concatemeric genomes for nine restriction endonucleases. J. Gen. Virol. 72, 157–168.CrossRefPubMedGoogle Scholar
  7. 7.
    Lindquester, G. J., Inoue, N., Allen, R. D., Castelli, J. W., Stamey, F. R., Dambaugh, T. R., O’Brian, J. J., Danovich, R. M., Frenkel, N., and Pellett, P. E. (1996) Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome. Arch. Virol. 141, 367–379.CrossRefPubMedGoogle Scholar
  8. 8.
    Dominguez, G., Black, J. B., Stamey, F. R., Inoue, N., and Pellett, P. E. (1996) Physical and genetic maps of the human herpesvirus 7 strain SB genome. Arch. Virol. 141, 2387–2409.CrossRefPubMedGoogle Scholar
  9. 9.
    Nicholas, J. (1996) Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J. Virol. 70, 5975–5989.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Jodi B. Black
    • 1
  • Philip E. Pellett
    • 1
  1. 1.Centers for Disease Control and PreventionAtlanta

Personalised recommendations